Alliancebernstein L.P. Amneal Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 195,319 shares of AMRX stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

195,319

Previous 200,319 2.5%

Holding current value

$1.71 Million

Previous $1.27 Million 27.75%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $32,100 - $44,150	-5,000 Reduced 2.5%	195,319 $1.63 Million
Q2 2024 Aug 14, 2024	BUY	$5.36 - $7.11 $161,443 - $214,153	30,120 Added 17.7%	200,319 $1.27 Million
Q1 2024 May 14, 2024	BUY	$5.24 - $6.34 $69,168 - $83,688	13,200 Added 8.41%	170,199 $1.03 Million
Q4 2023 Feb 14, 2024	SELL	$3.36 - $6.21 $28,862 - $53,343	-8,590 Reduced 5.19%	156,999 $952,000
Q3 2023 Nov 14, 2023	SELL	$2.76 - $4.59 $27,351 - $45,486	-9,910 Reduced 5.65%	165,589 $698,000
Q2 2023 Aug 15, 2023	SELL	$1.33 - $3.1 $8,578 - $19,995	-6,450 Reduced 3.54%	175,499 $544,000
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $15,494 - $32,940	12,200 Added 7.19%	181,949 $252,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $39,004 - $51,939	19,900 Added 13.28%	169,749 $337,000
Q3 2022 Nov 15, 2022	SELL	$2.02 - $3.62 $5,252 - $9,412	-2,600 Reduced 1.71%	149,849 $303,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $44,548 - $66,008	14,800 Added 10.75%	152,449 $485,000
Q1 2022 May 13, 2022	BUY	$3.9 - $4.89 $1,560 - $1,955	400 Added 0.29%	137,649 $574,000
Q3 2021 Nov 10, 2021	SELL	$4.31 - $5.64 $148,651 - $194,523	-34,490 Reduced 20.08%	137,249 $733,000
Q2 2021 Jul 30, 2021	BUY	$5.12 - $6.82 $150,476 - $200,439	29,390 Added 20.65%	171,739 $879,000
Q1 2021 May 06, 2021	SELL	$4.74 - $7.38 $164,478 - $256,086	-34,700 Reduced 19.6%	142,349 $958,000
Q4 2020 Feb 08, 2021	SELL	$3.95 - $5.42 $41,475 - $56,910	-10,500 Reduced 5.6%	177,049 $809,000
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $157,176 - $233,987	-44,400 Reduced 19.14%	187,549 $728,000
Q2 2020 Aug 13, 2020	BUY	$2.87 - $5.46 $52,808 - $100,464	18,400 Added 8.62%	231,949 $1.1 Million
Q1 2020 May 14, 2020	SELL	$2.46 - $5.35 $48,462 - $105,395	-19,700 Reduced 8.45%	213,549 $743,000
Q4 2019 Feb 18, 2020	BUY	$2.65 - $5.56 $20,140 - $42,256	7,600 Added 3.37%	233,249 $1.12 Million
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $195,566 - $606,340	85,400 Added 60.89%	225,649 $654,000
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $91,448 - $202,918	14,200 Added 11.27%	140,249 $1.01 Million
Q4 2018 Feb 13, 2019	SELL	$13.09 - $21.49 $22,253 - $36,533	-1,700 Reduced 1.33%	126,049 $1.71 Million
Q3 2018 Nov 08, 2018	BUY	$16.4 - $24.27 $21,319 - $31,551	1,300 Added 1.03%	127,749 $2.84 Million
Q2 2018 Aug 13, 2018	BUY	$13.95 - $20.2 $1.76 Million - $2.55 Million	126,449 New	126,449 $2.08 Million

Others Institutions Holding AMRX

# of Institutions

193

Shares Held

140M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.32B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Amneal Pharmaceuticals, Inc. Transaction History